Business Description
Bicycle Therapeutics PLC
NAICS : 325412
SIC : 2834
ISIN : US0887861088
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.71 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.27 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.16 | |||||
Beneish M-Score | -3.15 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | -22.1 | |||||
3-Year EPS without NRI Growth Rate | -24 | |||||
3-Year FCF Growth Rate | -21.7 | |||||
3-Year Book Growth Rate | 29.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 16.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.63 | |||||
9-Day RSI | 46.05 | |||||
14-Day RSI | 46.7 | |||||
6-1 Month Momentum % | 60.31 | |||||
12-1 Month Momentum % | 26.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.08 | |||||
Quick Ratio | 8.08 | |||||
Cash Ratio | 7.57 | |||||
Days Sales Outstanding | 438.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.4 | |||||
Shareholder Yield % | -1.91 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -701.93 | |||||
Net Margin % | -669.72 | |||||
FCF Margin % | -235.61 | |||||
ROE % | -59.39 | |||||
ROA % | -35.74 | |||||
ROIC % | -219.09 | |||||
ROC (Joel Greenblatt) % | -506.14 | |||||
ROCE % | -39.81 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 28.52 | |||||
PB Ratio | 2.31 | |||||
Price-to-Tangible-Book | 2.31 | |||||
EV-to-EBIT | -2.15 | |||||
EV-to-EBITDA | -2.24 | |||||
EV-to-Revenue | 14.04 | |||||
EV-to-Forward-Revenue | 13.38 | |||||
EV-to-FCF | -5.96 | |||||
Price-to-Net-Current-Asset-Value | 2.54 | |||||
Price-to-Net-Cash | 2.83 | |||||
Earnings Yield (Greenblatt) % | -46.51 | |||||
FCF Yield % | -7.38 |